Musa I, Wang Z, Yang N, Li X
Front Immunol. 2024; 15:1427563.
PMID: 39221239
PMC: 11363073.
DOI: 10.3389/fimmu.2024.1427563.
Ozmen Z, Kupeli M
Biochem Med (Zagreb). 2023; 33(3):030701.
PMID: 37841777
PMC: 10564156.
DOI: 10.11613/BM.2023.030701.
Premeaux T, Moser C, McKhann A, Hoenigl M, Yeung S, Pang A
Open Forum Infect Dis. 2022; 9(3):ofab570.
PMID: 35146038
PMC: 8826032.
DOI: 10.1093/ofid/ofab570.
Stasi A, Franzin R, Divella C, Sallustio F, Curci C, Picerno A
Front Immunol. 2021; 12:605212.
PMID: 33868226
PMC: 8047323.
DOI: 10.3389/fimmu.2021.605212.
Tang T, Cheng X, Truong B, Sun L, Yang X, Wang H
Pharmacol Ther. 2020; 219:107709.
PMID: 33091428
PMC: 7886970.
DOI: 10.1016/j.pharmthera.2020.107709.
Soluble CD40 in plasma and malignant pleural effusion with non-small cell lung cancer: A potential marker of prognosis.
Mu C, Qin P, Qu Q, Chen C, Huang J
Chronic Dis Transl Med. 2017; 1(1):36-41.
PMID: 29062985
PMC: 5643771.
DOI: 10.1016/j.cdtm.2015.02.010.
Serum soluble CD40 is associated with liver injury in patients with chronic hepatitis B.
Shen H, Bai B, Wang Y, Zhou G, Hou J, Hu Y
Exp Ther Med. 2015; 9(3):999-1005.
PMID: 25667667
PMC: 4316966.
DOI: 10.3892/etm.2015.2182.
Accelerated receptor shedding inhibits kidney injury molecule-1 (KIM-1)-mediated efferocytosis.
Gandhi R, Yi J, Ha J, Shi H, Ismail O, Nathoo S
Am J Physiol Renal Physiol. 2014; 307(2):F205-21.
PMID: 24829508
PMC: 4380482.
DOI: 10.1152/ajprenal.00638.2013.
Development and in vitro characterization of canine CD40-Ig.
Jochum C, Beste M, Stone D, Graves S, Storb R
Vet Immunol Immunopathol. 2008; 123(3-4):260-5.
PMID: 18387675
PMC: 2467396.
DOI: 10.1016/j.vetimm.2008.02.005.
Modulation of neuronal differentiation by CD40 isoforms.
Hou H, Obregon D, Lou D, Ehrhart J, Fernandez F, Silver A
Biochem Biophys Res Commun. 2008; 369(2):641-7.
PMID: 18312851
PMC: 3245987.
DOI: 10.1016/j.bbrc.2008.02.094.
A flow cytometry technique to study intracellular signals NF-kappaB and STAT3 in peripheral blood mononuclear cells.
Lafarge S, Hamzeh-Cognasse H, Chavarin P, Genin C, Garraud O, Cognasse F
BMC Mol Biol. 2007; 8:64.
PMID: 17663801
PMC: 1949834.
DOI: 10.1186/1471-2199-8-64.
Multivalent recombinant proteins for probing functions of leucocyte surface proteins such as the CD200 receptor.
Voulgaraki D, Mitnacht-Kraus R, Letarte M, Foster-Cuevas M, Brown M, Barclay A
Immunology. 2005; 115(3):337-46.
PMID: 15946251
PMC: 1782167.
DOI: 10.1111/j.1365-2567.2005.02161.x.
Gene therapy for liver transplantation using adenoviral vectors: CD40-CD154 blockade by gene transfer of CD40Ig protects rat livers from cold ischemia and reperfusion injury.
Ke B, Shen X, Gao F, Busuttil R, Lowenstein P, Castro M
Mol Ther. 2004; 9(1):38-45.
PMID: 14741776
PMC: 2913595.
DOI: 10.1016/j.ymthe.2003.10.011.
Cowpox virus encodes a fifth member of the tumor necrosis factor receptor family: a soluble, secreted CD30 homologue.
Panus J, Smith C, Ray C, Smith T, Patel D, Pickup D
Proc Natl Acad Sci U S A. 2002; 99(12):8348-53.
PMID: 12034885
PMC: 123070.
DOI: 10.1073/pnas.122238599.
Hyper immunoglobulin E response in mice with monoclonal populations of B and T lymphocytes.
de Lafaille M, Muriglan S, Sunshine M, Lei Y, Kutchukhidze N, Furtado G
J Exp Med. 2001; 194(9):1349-59.
PMID: 11696599
PMC: 2195981.
DOI: 10.1084/jem.194.9.1349.
Glucocorticoids upregulate CD40 ligand expression and induce CD40L-dependent immunoglobulin isotype switching.
Jabara H, Brodeur S, Geha R
J Clin Invest. 2001; 107(3):371-8.
PMID: 11160161
PMC: 199190.
DOI: 10.1172/JCI10168.
Epstein-Barr virus uses different complexes of glycoproteins gH and gL to infect B lymphocytes and epithelial cells.
Wang X, Kenyon W, Li Q, Mullberg J, Hutt-Fletcher L
J Virol. 1998; 72(7):5552-8.
PMID: 9621012
PMC: 110204.
DOI: 10.1128/JVI.72.7.5552-5558.1998.
The hyper-IgM (HIM) syndrome.
Ramesh N, Seki M, Notarangelo L, Geha R
Springer Semin Immunopathol. 1998; 19(4):383-99.
PMID: 9618764
DOI: 10.1007/BF00792598.
The Epstein-Barr virus BARF1 gene encodes a novel, soluble colony-stimulating factor-1 receptor.
Strockbine L, Cohen J, Farrah T, Lyman S, Wagener F, DuBose R
J Virol. 1998; 72(5):4015-21.
PMID: 9557689
PMC: 109629.
DOI: 10.1128/JVI.72.5.4015-4021.1998.
Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes.
Li Q, Spriggs M, Kovats S, Turk S, Comeau M, Nepom B
J Virol. 1997; 71(6):4657-62.
PMID: 9151859
PMC: 191687.
DOI: 10.1128/JVI.71.6.4657-4662.1997.